Kimberly M. Komatsubara, MD

Here we review the clinical data supporting these different plasma genotyping methodologies, and present a practical approach to the interpretation of the results of these tests.

Due to the delicate hemostatic balance in cancer patients, an understanding of both the clotting and bleeding risks in this population is crucial to effectively manage hematologic complications.

In this review, we discuss current management strategies, as well as future directions, for the management of uveal and conjunctival melanoma.